vs
百特国际(BAX)与RENAISSANCERE HOLDINGS LTD(RNR)财务数据对比。点击上方公司名可切换其他公司
百特国际的季度营收约是RENAISSANCERE HOLDINGS LTD的1.2倍($2.7B vs $2.2B),RENAISSANCERE HOLDINGS LTD净利率更高(23.5% vs -0.6%,领先24.1%),百特国际同比增速更快(3.0% vs -36.8%),过去两年RENAISSANCERE HOLDINGS LTD的营收复合增速更高(-11.9% vs -15.8%)
百特国际是总部位于美国伊利诺伊州迪尔菲尔德的跨国医疗健康企业,业务布局覆盖全球众多市场,专注于研发、生产及销售各类医疗相关产品与解决方案,为全球医疗机构和患者提供专业可靠的医疗支持。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商,核心业务覆盖再保险、常规保险两大板块,同时运营风险相关创新投资业务,为全球客户提供专业的风险对冲与保险解决方案。
BAX vs RNR — 直观对比
营收规模更大
BAX
是对方的1.2倍
$2.2B
营收增速更快
BAX
高出39.8%
-36.8%
净利率更高
RNR
高出24.1%
-0.6%
两年增速更快
RNR
近两年复合增速
-15.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $2.7B | $2.2B |
| 净利润 | $-15.0M | $515.8M |
| 毛利率 | 33.0% | — |
| 营业利润率 | 2.4% | — |
| 净利率 | -0.6% | 23.5% |
| 营收同比 | 3.0% | -36.8% |
| 净利润同比 | — | 72.6% |
| 每股收益(稀释后) | $0.36 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BAX
RNR
| Q1 26 | $2.7B | $2.2B | ||
| Q4 25 | $3.0B | $3.0B | ||
| Q3 25 | $2.8B | $3.2B | ||
| Q2 25 | $2.8B | $3.2B | ||
| Q1 25 | $2.6B | $3.5B | ||
| Q4 24 | $533.0M | $2.3B | ||
| Q3 24 | $2.7B | $4.0B | ||
| Q2 24 | $3.8B | $2.8B |
净利润
BAX
RNR
| Q1 26 | $-15.0M | $515.8M | ||
| Q4 25 | $-1.1B | $760.5M | ||
| Q3 25 | $-46.0M | $916.5M | ||
| Q2 25 | $91.0M | $835.4M | ||
| Q1 25 | $126.0M | $170.0M | ||
| Q4 24 | $-512.0M | $-189.7M | ||
| Q3 24 | $140.0M | $1.2B | ||
| Q2 24 | $-314.0M | $503.9M |
毛利率
BAX
RNR
| Q1 26 | 33.0% | — | ||
| Q4 25 | 19.4% | — | ||
| Q3 25 | 33.5% | — | ||
| Q2 25 | 35.3% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 37.5% | — |
营业利润率
BAX
RNR
| Q1 26 | 2.4% | — | ||
| Q4 25 | -24.5% | 42.5% | ||
| Q3 25 | 6.1% | 46.3% | ||
| Q2 25 | 6.8% | 41.8% | ||
| Q1 25 | 2.2% | -2.0% | ||
| Q4 24 | -25.5% | -3.6% | ||
| Q3 24 | 5.7% | 43.7% | ||
| Q2 24 | -5.0% | 25.0% |
净利率
BAX
RNR
| Q1 26 | -0.6% | 23.5% | ||
| Q4 25 | -37.9% | 25.6% | ||
| Q3 25 | -1.6% | 28.7% | ||
| Q2 25 | 3.2% | 26.1% | ||
| Q1 25 | 4.8% | 4.9% | ||
| Q4 24 | -96.1% | -8.3% | ||
| Q3 24 | 5.2% | 29.8% | ||
| Q2 24 | -8.2% | 17.8% |
每股收益(稀释后)
BAX
RNR
| Q1 26 | $0.36 | $6.57 | ||
| Q4 25 | $-2.21 | $16.16 | ||
| Q3 25 | $-0.09 | $19.40 | ||
| Q2 25 | $0.18 | $17.20 | ||
| Q1 25 | $0.25 | $3.27 | ||
| Q4 24 | $-0.99 | $-3.76 | ||
| Q3 24 | $0.27 | $22.62 | ||
| Q2 24 | $-0.62 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $4.3B |
| 总资产 | — | $53.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BAX
RNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $2.0B | $1.7B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $2.3B | $1.6B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.4B | $1.6B | ||
| Q2 24 | $2.1B | $1.6B |
总债务
BAX
RNR
| Q1 26 | — | — | ||
| Q4 25 | $9.5B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | $10.4B | $1.9B | ||
| Q3 24 | $10.4B | $1.9B | ||
| Q2 24 | $10.4B | $2.0B |
股东权益
BAX
RNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $6.1B | $11.6B | ||
| Q3 25 | $7.2B | $11.5B | ||
| Q2 25 | $7.3B | $10.8B | ||
| Q1 25 | $7.1B | $10.3B | ||
| Q4 24 | $7.0B | $10.6B | ||
| Q3 24 | $7.9B | $11.2B | ||
| Q2 24 | $7.6B | $10.2B |
总资产
BAX
RNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $20.1B | $53.8B | ||
| Q3 25 | $21.1B | $54.5B | ||
| Q2 25 | $21.0B | $54.7B | ||
| Q1 25 | $21.3B | $53.6B | ||
| Q4 24 | $25.8B | $50.7B | ||
| Q3 24 | $26.7B | $52.8B | ||
| Q2 24 | $26.3B | $51.6B |
负债/权益比
BAX
RNR
| Q1 26 | — | — | ||
| Q4 25 | 1.55× | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | 1.49× | 0.18× | ||
| Q3 24 | 1.33× | 0.17× | ||
| Q2 24 | 1.37× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | $76.0M | — |
| 自由现金流率自由现金流/营收 | 2.8% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
BAX
RNR
| Q1 26 | — | — | ||
| Q4 25 | $584.0M | $483.0M | ||
| Q3 25 | $237.0M | $1.6B | ||
| Q2 25 | $217.0M | $1.5B | ||
| Q1 25 | $-193.0M | $157.8M | ||
| Q4 24 | $488.0M | $778.9M | ||
| Q3 24 | $253.0M | $1.5B | ||
| Q2 24 | $115.0M | $1.2B |
自由现金流
BAX
RNR
| Q1 26 | $76.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率
BAX
RNR
| Q1 26 | 2.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度
BAX
RNR
| Q1 26 | 5.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率
BAX
RNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | 2.38× | 1.76× | ||
| Q1 25 | -1.53× | 0.93× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.81× | 1.26× | ||
| Q2 24 | — | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图